Difference between revisions of "Mesonephric remnant of the prostate gland"

Jump to navigation Jump to search
no edit summary
 
(4 intermediate revisions by the same user not shown)
Line 12: Line 12:
**Scant-to-moderate cytoplasm.<ref name=pmid12861057/>
**Scant-to-moderate cytoplasm.<ref name=pmid12861057/>
**Small/indistinct nucleoli.
**Small/indistinct nucleoli.
Note:
*May look like Gleason pattern 3 adenocarcinoma.


DDx:<ref name=pmid21606823/>
DDx:<ref name=pmid21606823/>
Line 23: Line 26:
==IHC==
==IHC==
Features:<ref name=pmid21606823/>
Features:<ref name=pmid21606823/>
*PAX8 +ve.
*[[PAX8]] +ve.
*PSA -ve (all).
*[[PSA]] -ve (all).
*PSAP -ve.<ref name=pmid12861057>{{Cite journal  | last1 = Bostwick | first1 = DG. | last2 = Qian | first2 = J. | last3 = Ma | first3 = J. | last4 = Muir | first4 = TE. | title = Mesonephric remnants of the prostate: incidence and histologic spectrum. | journal = Mod Pathol | volume = 16 | issue = 7 | pages = 630-5 | month = Jul | year = 2003 | doi = 10.1097/01.MP.0000074733.10777.78 | PMID = 12861057 }</ref>
*[[PSAP]] -ve.<ref name=pmid12861057/>
*CK34betaE12 +ve/-ve (diffuse +ve in 4/7 cases)
*[[CK34betaE12]] +ve/-ve (diffuse +ve in 4/7 cases)
*p63 -ve.
*[[p63]] -ve.
*AMACR +ve (focal).
*[[AMACR]] +ve (focal).


==See also==
==See also==
*[[Prostate gland]].
*[[Prostate gland]].
*[[Prostate cancer]].
*[[Prostate cancer]].
*[[Nephrogenic adenoma]].


==References==
==References==
48,466

edits

Navigation menu